Beylerli, Ozal,
Beilerli, Aferin,
Shumadalova, Alina,
Wang, Xiaoxiong,
Yang, Mingchun,
Sun, Hanran,
Teng, Lei (2022) Glioblastoma (GBM) is the most common and aggressive tumor of the central nervous system, which has
KHABIBOV, M.,
GARIFULLIN, A.,
KHAMITOV, F.,
KHALIKOVA, L.,
BOUMBER, Y.,
KHADDOUR, K.,
FERNANDEZ, M.,
KUZNETSOVA, N.,
KIT, O.,
KHARIN, L. (2022) Glioblastoma multiforme (GBM) is the most aggres‑
sive type of primary brain tumor
Jiang, HP,
Zhang, DZ,
Aleksandrovich, KD,
Ye, JY,
Wang, LX,
Chen, XF,
Gao, M,
Wang, XZ,
Yan, T,
Yang, H,
Lu, EZ,
Liu, WW,
Zhang, C,
Wu, JN,
Yao, PL,
Sun, ZY,
Rong, X,
Timofeevich, SA,
Mahmutovich, SS,
Zheng, ZX,
Chen, X,
Zhao, SG (2022) , the antineoplastic effect of pectolinarigenin on
glioblastoma (GBM) remains unclear. In the present study, we found
LIU, Z.,
WANG, X.,
YANG, G.,
ZHONG, C.,
ZHANG, R.,
YE, J.,
ZHONG, Y.,
HU, J.,
OZAL, B.,
ZHAO, S. (2020) RNA-related ceRNA regulatory network, in
glioblastoma (GBM) has not been fully elucidated. The goal
CHEN, Q.,
HAN, B.,
MENG, X.,
DUAN, C.,
YANG, C.,
WU, Z.,
MAGAFUROV, D.,
ZHAO, S.,
JIANG, C.,
CAI, J.,
SAFIN, S (2019) accelerates the initiation, progression, chemoresistance and immune evasion of
glioblastoma (GBM). However
Радиомический анализ для объективизации диагностики и комплексного лечения глиобластомыRadiomic Study for Objectification of Diagnostics and Complex Treatment of
Glioblastoma